Medifast
Price
Price
Historical dividends and forecast
The next dividend will be paid on 07.02.2025
CHART BY
Frequently asked questions
What is Medifast's market capitalization?
What is Medifast's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Medifast?
What are the analyst ratings and target price for Medifast's stock?
What is Medifast's revenue over the trailing twelve months?
What is the EBITDA for Medifast?
What is the free cash flow of Medifast?
What is the 5-year beta of Medifast's stock?
How many employees does Medifast have, and what sector and industry does it belong to?
What is the free float of Medifast's shares?
Financials
Market Cap
$200.16M5Y beta
1.18EPS (TTM)
$0.669Free Float
10.66MP/E ratio (TTM)
27.33Revenue (TTM)
$674.48MEBITDA (TTM)
$23.72MFree Cashflow (TTM)
$15.14MPricing
Analyst Ratings
The price target is $21.25 and the stock is covered by 2 analysts.
Buy
0
Hold
1
Sell
1
Information
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
634
Biotechnology & Drugs
Consumer Staples
Identifier
ISIN
Primary Ticker